News

Curetis and Laboratorios LETI Sign Exclusive Distribution Agreement for UnyveroTM in Spain and Portugal

gennaio 9, 2014

Human Health

Portfolio

Back

Download

PDF

Curetis AG today announced that the company has closed an exclusive distribution agreement in Spain and Portugal with Laboratorios LETI, which includes all existing and future Unyvero instruments and consumables. LETI is a biopharmaceutical company based in Tres Cantos, near Madrid, Spain. Its diagnostics business unit distributes and markets a broad portfolio of in vitro diagnostics (IVD) and research products, among other offerings.